| Issue Number | 4878 |
|---|---|
| Summary | [DIS] Drug Summaries Lists Report - Modifications for FDA Approval element attributes and Drug Type |
| Created | 2020-09-09 16:42:19 |
| Issue Type | Improvement |
| Submitted By | Juthe, Robin (NIH/NCI) [E] |
| Assigned To | Kline, Bob (NIH/NCI) [C] |
| Status | Closed |
| Resolved | 2020-10-22 13:29:44 |
| Resolution | Fixed |
| Path | /home/bkline/backups/jira/ocecdr/issue.274438 |
We'd like to modify the Drug Summaries Lists report to display information about the new FDA approval attributes (accelerated approval, approved in children) as well as the drug type information. Requirements coming soon.
I've attached requirements for this issue.
The requirements are mostly very clear, so thanks for that. I do have one or two minor questions.
Not sure what to do with "and/or" for FDA approval status. If you check both boxes, is it AND or is it OR? Those are two separate attributes, so presumably both could be set to "Yes" and you could be asking for the selection to pick up only those drugs which have both set to "Yes" (AND). Or you could be asking that we pick up drugs which have either attribute set to "Yes" (OR).
Any preferences for the positions of the new columns and/or the new fieldset boxes? Or the new Options checkbox?
OK if we include on the Drug Type select list the values we find in the query term table? Seems more robust than hard-wiring the values into the code.
#3 - I agree with using the values in the query term table. I'm checking with Christina on her preferences for #1 and #2 and will get back to you.
#1 - please OR this selection. In other words, if both accelerated approval and approved in children are checked, please display drugs that have either attribute set to "Yes".
#2 - no preferences. Please feel free to propose the layout.
Thanks!
Don't forget to reassign tickets back to me when you're ready for me to resume work on them. 🙂
Implemented and installed on DEV.
Verified on DEV. Thanks!
It looks like, the program requires a publishable version of the DIS document before they show up on the report. If that is the case, was it intentional?
That has nothing to do with this enhancement. The report has always worked that way. On 2008-09-10 Margaret told Volker "Diana and Deb would like the report to only list summaries that have a publishable version and that are not blocked."
That's good to know. Thanks!
Verified on QA. Thanks!
Verified on PROD. Thanks!
| File Name | Posted | User |
|---|---|---|
| Drug Lists report _QA.PNG | 2020-11-12 15:25:02 | Osei-Poku, William (NIH/NCI) [C] |
| OCECDR 4878 Requirements.docx | 2020-09-24 13:19:25 | Juthe, Robin (NIH/NCI) [E] |
Elapsed: 0:00:00.001501